Skip to main content
Home
  • ALL Specialities ALL Specialities
    Home
    Home

    Kate Johnson

    News

    Thirty years of epilepsy therapy: ‘Plus ça change, plus c’est la même chose’?

    Author:
    Kate Johnson
    Publish date: April 18, 2023

    To celebrate our 30th year in print, Neurology Reviews invited experts to look back on 30 years of progress in their subspecialty. In this...

    • Read More

    News

    Lebrikizumab monotherapy for AD found safe, effective during induction

    Author:
    Kate Johnson
    Publish date: March 15, 2023

    Atopic dermatitis (AD) monotherapy with the lebrikizumab, an interleukin-13 inhibitor, was shown to be both...

    • Read More

    News

    Causal link found between childhood obesity and adult-onset diabetes

    Author:
    Kate Johnson
    Publish date: March 9, 2023

    Bigger children have increased risks for almost all subtypes of adult-onset diabetes, a Mendelian randomization study indicates.

    • Read More

    News

    Oncologist stars in film and shares philosophy on death

    Author:
    Kate Johnson
    Publish date: February 22, 2023

    When a New York oncologist approached the French actress and film director Emmanuelle Bercot in Manhattan, he was thinking big.

    • Read More

    News

    AD outcomes improved with lebrikizumab and topical steroids

    Author:
    Kate Johnson
    Publish date: January 17, 2023

    The percentage of patients who achieved the combined endpoint was more than double for the lebrikizumab plus TCS group vs. the group on TCS alone...

    • Read More

    News

    Cancer clinics begin to accommodate patients demanding new cancer detection tests

    Author:
    Kate Johnson
    Publish date: January 9, 2023

    Sales teams are making a big push for multicancer early detection tests.

    • Read More

    News

    Cochrane Review bolsters case that emollients don’t prevent AD

    Author:
    Kate Johnson
    Publish date: December 22, 2022

    But that message is being diluted by a stream of contradictory conclusions from poor-quality systematic reviews, authors say.

    • Read More

    News

    A single pediatric CT scan raises brain cancer risk

    Author:
    Kate Johnson
    Publish date: December 12, 2022

    "CT examinations should only be used when necessary, and if they are used, the lowest achievable dose should be applied."

    • Read More

    News

    Study comparing surgical and N95 masks sparks concern

    Author:
    Kate Johnson
    Publish date: December 6, 2022

    The findings are not consistent with those of many other studies on this topic.

    • Read More

    News

    Will a one-dose drug mean the end of sleeping sickness?

    Author:
    Kate Johnson
    Publish date: November 30, 2022

    The drug has “the potential to revolutionize treatment” for the disease.

    • Read More

    News

    Study affirms shorter regimens for drug-resistant tuberculosis

    Author:
    Kate Johnson
    Publish date: November 29, 2022

    The findings validate the World Health Organization’s current recommendation.

    • Read More

    News

    New genetic variant linked to maturity-onset diabetes of the young

    Author:
    Kate Johnson
    Publish date: November 29, 2022

    The reported variant in Greenlandic Inuit individuals has the largest population impact of any previously reported variant within a MODY gene.

    • Read More

    News

    Study finds chronic jet lag–like body clocks in people with HIV

    Author:
    Kate Johnson
    Publish date: November 28, 2022

    The mistimed circadian phase in people living with HIV is linked to later sleep onset and earlier waking and has “important potential implications...

    • Read More

    News

    New statement guides the diagnosis of pediatric anxiety

    Author:
    Kate Johnson
    Publish date: November 2, 2022

    Clinicians must distinguish between normal anxiety, situational anxiety, and specific anxiety disorder. “It’s detective work.”

    • Read More

    News

    Rapid action or sustained effect? Methotrexate vs. ciclosporin for pediatric AD

    Author:
    Kate Johnson
    Publish date: November 2, 2022

    In the TREAT trial, 103 patients with AD (mean age, 10 years) who had not responded to topical treatment, were randomly assigned to oral...

    • Read More

    Pages

    • « first
    • 1
    • 2
    • 3
    • 4
    • 5
    • 6
    • 7
    • 8
    • 9
    • …
    • last »

    Privacy Policy

    Terms of Use

    Editorial Policy

    Cookie Policy

    Ad Policy

    Medscape Customer Support

    Frequently Asked Questions

     

    Advertise with MDedge

    See more with MDedge! See our Other Publications

    MDedge: Keeping You Informed. Saving You Time.

    Copyright  © 2024 Frontline Medical Communications Inc., 283-299 Market Street, 2 Gateway Center, 4th Floor, Newark, NJ 07102. All rights reserved. Unauthorized use prohibited. The information provided is for educational purposes only. Use of this Web site is subject to the medical disclaimer.

    • All Specialties
      • MDedge Home
      • Cardiology
      • Clinician Reviews
      • Dermatology
      • Emergency Medicine
      • Endocrinology/Diabetes
      • Family Medicine
      • Federal Practitioner
      • Gastroenterology
      • Hematology/Oncology
      • Infectious Disease
      • Internal Medicine
      • Neurology
      • Obstetrics And Gynecology
      • Pediatrics
      • Psychiatry
      • Pulmonology
      • Rheumatology
      • Surgery
    • MDedge Home
    • Cardiology
    • Clinician Reviews
    • Dermatology
    • Emergency Medicine
    • Endocrinology/Diabetes
    • Family Medicine
    • Federal Practitioner
    • Gastroenterology
    • Hematology/Oncology
    • Infectious Disease
    • Internal Medicine
    • Neurology
    • Obstetrics And Gynecology
    • Pediatrics
    • Psychiatry
    • Pulmonology
    • Rheumatology
    • Surgery